Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke
International Immunopharmacology · 2026-12 · 190 · 117539
DOI: 10.1016/j.intimp.2026.117539 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Bashir Bietar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Faculty of Medicine, Dalhousie University, 1276 South Park St, Rm 379 Bethune Building Halifax, Nova Scotia, B3H 2Y9, Ca…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Neuroinflammatory Diseases, Stroke, Cannabinoids. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dalhousie University Faculty of Medicine.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke triggers neuroinflammation that can drive CNS injury-induced immunodepression syndrome (CIDS), a peripheral immunosuppressive state associated with increased infection risk. The endocannabinoid system, particularly cannabinoid receptor type 2 (CB2), represents a promising immunomodulatory target because of its anti-inflammatory actions and limited psychoactive liability. In this study, we investigated whether CB2 receptor activation confers neuroprotection and preserves systemic immune responsiveness in a murine photothrombotic stroke (PTS) model. Male C57BL/6 mice underwent PTS or sham surgery and were treated before stroke induction with the non-selective CB1/CB2 agonist WIN-55212, receptor antagonists, the selective CB2 agonist HU-308, or vehicle. Neurological deficits, infarct volume, cerebral inflammatory gene expression, and intestinal leukocyte-endothelial interactions following lipopolysaccharide (LPS) challenge were assessed using Neuroscore, TTC staining, RT-qPCR, and intravital microscopy. SIM-A9 microglia were used to evaluate the effects of HU-308 on viability and cytokine release under inflammatory conditions. PTS induced a CIDS-like phenotype characterized by reduced baseline leukocyte rolling and a markedly blunted leukocyte adhesion response following LPS challenge. Non-selective cannabinoid receptor activation improved neurological scores and reduced infarct size, while CB2 blockade abolished this protection. Selective CB2 activation with HU-308 reduced infarct volume, improved neurological outcome, and suppressed stroke-associated TNF and IL-6 expression in the ischemic hemisphere. In vitro, HU-308 reduced TNF release from LPS-stimulated microglia, while IL-4 enhanced microglial viability and IL-10 production. Importantly, HU-308 preserved leukocyte adhesion after LPS challenge following stroke, suggesting maintained peripheral immune responsiveness. These findings identify CB2 receptor activation as a promising neuroimmune strategy that limits acute stroke injury while attenuating the development of CIDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care, Faculty of Medicine, Dalhousie University, 1276 South Park St, Rm 379 Bethune Building Halifax, Nova Scotia, B3H 2Y9, Canada; Department of Pharmacology, Faculty of Medicine, Dalhousie Unive…
- Faculty of Medicine, Dalhousie University, 5850 College Street, Halifax, Nova Scotia, B3H 4R2, Canada.
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, 5850 College Street, Halifax, Nova Scotia, B3H 4R2, Canada.
- Department of Anesthesia, Pain Management and Perioperative Medicine, Faculty of Medicine, Dalhousie University, 5850 College Street, Halifax, Nova Scotia, B3H 4R2, Canada.
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, 5850 College Street, Halifax, Nova Scotia, B3H 4R2, Canada; Department of Anesthesia, Pain Management and Perioperative Medicine, Faculty of Medicin…
Förderung
- Dalhousie University Faculty of Medicine
Zitieren
APA
Bietar, B., Tanner, S., Abdolmohammadi, P., Kasheke, G., Zhou, J., & Lehmann, C. (2026). Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke. International Immunopharmacology, 190, 117539. https://doi.org/10.1016/j.intimp.2026.117539
Vancouver
Bietar B, Tanner S, Abdolmohammadi P, Kasheke G, Zhou J, Lehmann C. Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke. International Immunopharmacology. 2026;190:117539. doi:10.1016/j.intimp.2026.117539
BibTeX
@article{Bietar2026,
author = {Bietar, Bashir and Tanner, Sophie and Abdolmohammadi, Pouria and Kasheke, Gracious and Zhou, Juan and Lehmann, Christian},
title = {Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke},
journal = {International Immunopharmacology},
year = {2026},
volume = {190},
pages = {117539},
doi = {10.1016/j.intimp.2026.117539}
}
EUVIMED